Canopy Growth's first line of CBD
products are available for purchase through e-commerce platform
available at www.firstandfree.com
DENVER, Dec. 12, 2019 /PRNewswire/ - Canopy Growth
Corporation, USA, LLC (TSX: WEED)
(NYSE: CGC) ("Canopy Growth" or the "Company") today announced the
launch of First & Free – a hemp-derived CBD product line
offered in a variety of formats, including softgels, oil drops and
creams. The products will be available for purchase on the
company's first e-commerce site: www.firstandfree.com.
Perfected through state-of-the-art technology and rigorous
testing, First & Free products are created by extracting
and isolating derivatives from the hemp plant to produce pure and
consistent CBD formulations that are packaged in easy-to-use
formats.
"First & Free marks a new way for US consumers to
purchase quality CBD products from a trusted source," said Rade
Kovacevic, President, Canopy Growth. "Through state-of-the art
extraction methods, strict quality control measures, and scientific
research, we are delivering a best-in-class product to the
market."
At launch, the First & Free brand will offer the
following hemp-derived CBD products:
- First & Free Oil Drops
-
- Unflavored 25 mg per mL (750 mg per 30 mL bottle)
- Peppermint flavor 25 mg per mL (750 mg per 30 mL bottle)
- First & Free Softgels
-
- 250 mg CBD carton (10 softgels)
- 750 mg CBD bottle (30 softgels)
- 1500 mg CBD bottle (30 softgels)
- First & Free Creams*
-
- 2500 mg Everyday Cream (CBD Only)
- 2500 mg Motion Cream (CBD + Arnica)
- 2500 mg Revitalize Cream (CBD + Capsaicin)
Canopy Growth is committed to selling only high-quality, tested
and reliable products, and ensuring it makes no claims unless
clinically validated. This means selling First & Free
products only in states where permissible under state law in order
to ensure compliance with state consumer protection mandates and
following the most stringent state laws regarding sale of CBD. The
Company is also abiding by existing FDA regulations for
manufacturing, labeling and marketing dietary supplements.
For more information, please
visit https://www.firstandfree.com/
Here's to Future (United States
made, First & Free CBD) Growth.
* Creams coming soon
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp
and cannabis device company, offering distinct brands and curated
cannabis varieties in dried, oil and Softgel capsule forms, as well
as medical devices through Canopy Growth's subsidiary, Storz &
Bickel GMbH & Co. KG. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time. Canopy Growth has
operations in over a dozen countries across five continents.
Canopy Growth's medical division, Spectrum Therapeutics is
proudly dedicated to educating healthcare practitioners, conducting
robust clinical research, and furthering the public's understanding
of cannabis, and has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Spectrum
Therapeutics sells a range of full-spectrum products using its
colour-coded classification Spectrum system as well as single
cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo
Smoke banners. Tweed is a globally recognized cannabis brand which
has built a large and loyal following by focusing on quality
products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange
and New York Stock Exchange to our continued international
expansion, pride in advancing shareholder value through leadership
is engrained in all we do at Canopy Growth. Canopy Growth has
established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth
Rogen, breeding legends DNA Genetics and Green House Seeds,
and Fortune 500 alcohol leader Constellation Brands, to name but a
few. Canopy Growth operates eleven licensed cannabis production
sites with over 10.5 million square feet of production capacity,
including over one million square feet of GMP certified production
space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news
release contains "forward-looking statements" within the meaning of
the United States Private Securities Litigation Reform Act of 1995
and "forward-looking information" within the meaning of applicable
Canadian securities legislation. Often, but not always,
forward-looking statements and information can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements or information involve known and unknown
risks, uncertainties and other factors which may cause the actual
results, performance or achievements of Canopy Growth or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release. Examples of such statements include statements with
respect to future product format offerings. Risks, uncertainties
and other factors involved with forward-looking information could
cause actual events, results, performance, prospects and
opportunities to differ materially from those expressed or implied
by such forward-looking information, including the Company's
ability to establish and maintain CBD product availability in the
US, and such risks contained in the Company's annual information
form dated June 25, 2019 and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. Although the Company
believes that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this
news release are reasonable, undue reliance should not be placed on
such information and no assurance can be given that such events
will occur in the disclosed time frames or at all. The
forward-looking information and forward-looking statements included
in this news release are made as of the date of this news release
and the Company does not undertake an obligation to publicly update
such forward-looking information or forward-looking information to
reflect new information, subsequent events or otherwise unless
required by applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canopy-growth-introduces-first--free---a-line-of-branded-hemp-derived-cbd-products-to-the-us-market-300973966.html
SOURCE Canopy Growth Corporation